Deanna M. Mcleod
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Targeting common EGFR mutations in non-small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors.
Journal: Journal of the National Cancer Institute
Published: October 24, 2025
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma.
Journal: Therapeutic advances in medical oncology
Published: February 26, 2025
Changes in female cancer diagnostic billing rates over the COVID-19 period in the Ontario Health Insurance Plan.
Journal: Therapeutic advances in medical oncology
Published: December 17, 2024
A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer.
Journal: Therapeutic advances in medical oncology
Published: November 16, 2022
Correction: Karrow et al. Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development. Vaccines 2021, 9, 1351.
Journal: Vaccines
Published: January 10, 2022
Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review.
Journal: Therapeutic advances in medical oncology
Published: December 08, 2021
Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development.
Journal: Vaccines
Published: October 13, 2021
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: July 30, 2021
Canadian consensus on TRK-inhibitor therapy for NTRK fusion-positive sarcoma.
Journal: International journal of cancer
Published: February 24, 2021
Last Updated: 09/26/2026